Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. WW
WW logo

WW Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy WW International Inc (WW) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
10.000
1 Day change
-8.93%
52 Week Range
105.210
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

WW International Inc is not a strong buy for a beginner investor with a long-term focus at this time. The technical indicators are bearish, financial performance is weak, and there are no significant positive catalysts or trading signals to support an immediate investment. It is better to wait for clearer signs of recovery or improvement.

Technical Analysis

The technical indicators suggest a bearish trend. The MACD is below 0 and negatively contracting, RSI is neutral at 21.762, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support is at 10.37, and resistance is at 12.021. The stock has a 60% chance to drop -0.6% in the next day and -4.43% in the next month.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
10
Buy
4

Positive Catalysts

  • Gross margin improved slightly YoY to 69.99%.

Neutral/Negative Catalysts

  • Analyst price target was lowered from $34.50 to $

  • No recent news or significant trading trends from hedge funds, insiders, or Congress.

Financial Performance

In Q4 2025, revenue decreased to $162.81M (-11.71% YoY), net income dropped to -$5.83M (-123.22% YoY), and EPS fell to -0.58 (-287.10% YoY). Gross margin increased slightly to 69.99% (+1.33% YoY). Overall, financial performance is weak.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Morgan Stanley recently lowered the price target from $34.50 to $21 and maintained an Equal Weight rating. Analysts highlight a faster-than-expected shift from behavioral to clinic focus, with both upsides and negative trade-offs.

Wall Street analysts forecast WW stock price to rise
1 Analyst Rating
Wall Street analysts forecast WW stock price to rise
0 Buy
1 Hold
0 Sell
Hold
Current: 10.000
sliders
Low
38
Averages
38
High
38
Current: 10.000
sliders
Low
38
Averages
38
High
38
Morgan Stanley
Equal Weight
downgrade
$21
AI Analysis
2026-04-01
Reason
Morgan Stanley
Price Target
$21
AI Analysis
2026-04-01
downgrade
Equal Weight
Reason
Morgan Stanley lowered the firm's price target on WW to $21 from $34.50 and keeps an Equal Weight rating on the shares. A mix shift from behavioral to clinic is happening far faster than the firm anticipated, but this comes with upside as well as "negative trade-offs," the analyst tells investors.
Morgan Stanley
Equal Weight
downgrade
$41 -> $38
2025-11-07
Reason
Morgan Stanley
Price Target
$41 -> $38
2025-11-07
downgrade
Equal Weight
Reason
Morgan Stanley lowered the firm's price target on WW to $38 from $41 and keeps an Equal Weight rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for WW
Unlock Now

People Also Watch